Correlation Between Ascendis Pharma and G2D Investments

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ascendis Pharma and G2D Investments at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascendis Pharma and G2D Investments into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ascendis Pharma AS and G2D Investments, you can compare the effects of market volatilities on Ascendis Pharma and G2D Investments and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascendis Pharma with a short position of G2D Investments. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascendis Pharma and G2D Investments.

Diversification Opportunities for Ascendis Pharma and G2D Investments

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between Ascendis and G2D is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Ascendis Pharma AS and G2D Investments in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on G2D Investments and Ascendis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascendis Pharma AS are associated (or correlated) with G2D Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of G2D Investments has no effect on the direction of Ascendis Pharma i.e., Ascendis Pharma and G2D Investments go up and down completely randomly.

Pair Corralation between Ascendis Pharma and G2D Investments

Assuming the 90 days trading horizon Ascendis Pharma AS is expected to generate 0.84 times more return on investment than G2D Investments. However, Ascendis Pharma AS is 1.19 times less risky than G2D Investments. It trades about 0.05 of its potential returns per unit of risk. G2D Investments is currently generating about -0.04 per unit of risk. If you would invest  4,842  in Ascendis Pharma AS on September 1, 2024 and sell it today you would earn a total of  653.00  from holding Ascendis Pharma AS or generate 13.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.22%
ValuesDaily Returns

Ascendis Pharma AS  vs.  G2D Investments

 Performance 
       Timeline  
Ascendis Pharma AS 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ascendis Pharma AS are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ascendis Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.
G2D Investments 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in G2D Investments are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong fundamental indicators, G2D Investments is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Ascendis Pharma and G2D Investments Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ascendis Pharma and G2D Investments

The main advantage of trading using opposite Ascendis Pharma and G2D Investments positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascendis Pharma position performs unexpectedly, G2D Investments can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in G2D Investments will offset losses from the drop in G2D Investments' long position.
The idea behind Ascendis Pharma AS and G2D Investments pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device